INTRODUCTION
Immunoglobulin E (IgE)-dependent mast cell (MC) activation plays an important role in the development of allergy. The cross-linking of allergen-specific IgE bound to its high-affinity receptor, FcεRI, results in a series of molecular events leading to nuclear factor (NF)-B activation [1, 2] and subsequent cytokine production. Many MC-derived cytokines, such as tumor necrosis factor (TNF), are regulated by transcription factor NF-B [3] . Five mammalian NF-B proteins have been identified including NF-B1 (p50 and its precursor p105), NF-B2 (p52 and its precursor p100), RelA/p65, RelB, and cRel [3] . The predominant form of NF-B in many cell types is a p65:p50 heterodimer. A family of inhibitory proteins, including inhibitor of B (IB)␣, IB␤, and IBε, which bind to NF-B and mask its nuclear localization signal, causing its localization in the cytoplasm, controls the activity of NF-B [3] . Phosphorylation and degradation of IB allow NF-B to translocate to the nucleus and to bind DNA to initiate gene expression. Thus, IB plays an essential role in the control of NF-B activity. Diverse signaling proteins have been shown to be involved directly in IB phosphorylation and degradation. IB kinase (IKK) is activated and responsible for cytokine interleukin (IL)-1 and TNF-induced IB phosphorylation [3, 4] . In macrophages, NF-B activation is also mediated by c-Src tyrosine phosphorylation of IB␣ [5] . Additional proteins, which interact directly with IB and regulate its activity, include c-Abl [6] , phosphoinositide-3 kinase (PI-3K) [7] , mcalpain [8] , protein kinase C (PKC) [9, 10] , and many others [3] . It is likely that a specific protein involved in the regulation of IB activity is dependent on the specific stimuli and cell types. Although the biological relevance of IgE-dependent NF-B activation in allergy is obvious, the way in which antigen (Ag) ϩ IgE induces NF-B activation in MC is still unclear.
IKK is a complex composed of three subunits: IKK␣ (IKK1), IKK␤ (IKK2), and IKK␥ [NF-B essential modulator (NEMO)]. IKK␣ and IKK␤ are the catalytic subunits, and IKK␥ is the regulatory subunit [3, 4] . NF-B activation by TNF, IL-1, or lipopolysaccharide is blocked completely in the absence of IKK␥ and strongly reduced in the absence of IKK␤ [11] . IKK␣ is dispensable for cytokine-induced IB degradation [11] but is critical for cytokine-induced transcription of NF-B target genes by inducing histone phosphorylation [12, 13] . In MC, a role for IKK in Ag ϩ IgEinduced NF-B activation and gene expression remains to be determined.
We demonstrated that a cell-permeable peptide targeting  IKK and four individual chemical IKK inhibitors [15 deoxyprostaglandin J 2 (15dPGJ 2 ) , BMS-345541, SC-514, and sulindac] significantly inhibited Ag ϩ IgE-induced TNF production by MC. IKK␣ is rapidly phosphorylated in MC after Ag ϩ IgE stimulation. Inhibition of IgE-dependent IKK phosphorylation by sulindac correlates with decreased NF-B activation and TNF production. Thus, IKK is likely involved in FcεRI-induced TNF production by MC.
MATERIALS AND METHODS

Antibodies
Antibodies to IKK␣, phosphor (p)-IKK␣ (Ser180)/IKK␤ (Ser181), IB␣, and p-IB␣ (Ser-32) were purchased from Cell Signaling Technology (Beverly, MA). Anti-IKK␤ (clone 10AG2) was obtained from Upstate (Charlottesville, VA). Anti-␤-actin (H-196) and antibodies to NF-B p65, NF-B p50 (H-119), IB␤ (S-20), and IKK␤ (H-470, partially cross-reactive with IKK␣) were purchased from Santa Cruz Biotechnology (CA).
MC and stimulation
Murine bone marrow-derived MC (BMMC) were obtained by culturing bone marrow cells with 10% WEHI-3B-conditioned medium as a source of IL-3 [14] . After 4 -6 weeks, MC purity of Ͼ99% was achieved, as assessed by toluidine blue staining of fixed cytocentrifuge preparations. For IgE-dependent activation studies, BMMC were sensitized overnight in fresh complete medium supplemented with T1B141-conditioned medium containing IgE directed against trinitrophenyl (TNP) at a ratio of 3:1. After washing, cells were stimulated with TNP-bovine serum albumin (BSA; 10 ng/ml, Biosearch Technologies, Inc., Novato, CA) for indicated times. In experiments with inhibitors, BMMC were treated with these inhibitors before stimulation with TNP-BSA, including pyrrolidine dithiocarbomate {PDTC; Sigma-Aldrich (St. Louis, MO), a NF-B inhibitor [15] }, SC-514 {EMD Biosciences Inc. (San Diego, CA), an IKK␤ inhibitor [16] }, 15dPGJ 2 (EMD Biosciences, an inhibitor for IKK␣ and IKK␤ [17] ), a cell-permeable, NEMO-binding, domain-binding peptide (EMD Biosciences, an inhibitor for IKK␣ and IKK␤, according to the manufacturer), BMS-345541 (a kind gift from Dr. James R. Burke, Bristol-Myers Squibb, New York, NY, an inhibitor for IKK␣ and IKK␤ [18] ) for 1 h or indicated times, or sulindac (Sigma-Aldrich, an IKK␤ inhibitor [19] ) for 1 or 2 h before Ag stimulation.
Preparation of nuclear extracts
Nuclear protein extracts were obtained using a nuclear extract kit (ActiveMotif, Carlsbad, CA), according to the manufacturer's protocol. Cytoplasmic fractions were also saved. All preparation procedures were carried out at 4°C. Total protein concentrations were determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA).
Electrophoretic mobility shift assays (EMSA)
A consensus double-stranded NF-B oligonucleotide (Promega, Madison, WI, 5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј) was used for EMSA. Probelabeling was accomplished by treatment with T4 kinase (Promega) in the presence of 32 P-adenosine 5Ј-triphosphate (Amersham Biosciences, Piscataway, NJ). Labeled oligonucleotides were purified on a Sephadex G-25 M column (Amersham Biosciences). Nuclear protein (10 g) was added to 10 l vol binding reaction with 1 g poly(dI-dC; Amersham Biosciences) and incubated at room temperature for 15 min. Labeled, double-stranded NF-B oligonucleotide was added to each reaction mixture, incubated at room temperature for 30 min, and separated by electrophoresis on a 6% polyacrylamide gel in 0.5 ϫ Tris-boric acids-EDTA buffer. Gels were vacuum-dried and subjected to autoradiography. Cold competition was done by adding 1 l (1.75 M) specific unlabeled, double-stranded probe to the reaction mixture. Unlabeled, double-stranded oligonucleotide (1 l, 1.75 M), which does not bind NF-B, was used for nonspecific competition. Polyclonal antibodies to p50 and p65 (1 g/10 l, Santa Cruz Biotechnology) were used for supershift assays for NF-B proteins.
Immunoblotting
Denatured proteins were separated by electrophoresis on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) along with molecular weight markers. Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories), which were blocked with 5% nonfat dried milk in Tris-buffered saline that contained 0.1% Tween-20. The membranes were probed with the specific primary antibody and an appropriate secondary horseradish peroxidase-conjugated antibody (anti-rabbit IgG, Cedarlane, Hornby, ON, Canada; or anti-goat IgG, Santa Cruz Biotechnology) and visualized by enhanced chemiluminescence.
TNF assay
TNF protein levels in supernatants were measured using antibodies from R&D Systems (Minneapolis, MN) by enzyme-linked immunosorbent assay (ELISA) as described previously [14, 20] . The detection limit was 10 pg/ml. TNF mRNA was determined by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis using Assays-on-Demand TM reagents containing 6-carboxy fluorescein dye-labeled TaqMan minor groove-binding probes (Applied Biosystems), according to the manufacturer's protocol [20] . Glyceraldehyde 3-phosphate dehydrogenase was used as an endogenous reference. Data were analyzed using the relative standard curve method according to the manufacturer's protocol, and values from untreated MC were used as the calibrator. Thus, data are expressed as the fold-increase relative to untreated MC.
RESULTS
IKK inhibitors, a NEMO-binding peptide, 15dPGJ 2 , BMS-345541, SC-514, and sulindac blocked IgE ϩ Ag-induced TNF production by mouse BMMC (mBMMC)
To determine if IKK plays a role in IgE-dependent TNF production by MC, various IKK inhibitors were used. These include a cell-permeable peptide targeting the regulatory subunit of the IKK complex, the NEMO-binding, domain-binding peptide, and four chemical compounds that have inhibitory effects on IKK␣ or IKK␤, including sulindac, SC-514, 15dPGJ 2 , and BMS-345541. mBMMC, after IgE sensitization, were pretreated with these inhibitors for 1 h and stimulated with TNP-BSA (10 ng/ml) for 4 h. Cell-free supernatants were used to determine TNF production by ELISA. Treatment with the NEMO-binding peptide (150 M) but not the control peptide (150 M) inhibited TNP-induced TNF production (Fig. 1a) . Similarly, all four chemical IKK inhibitors, 15dPGJ 2 , BMS-345541, SC-514, and sulindac, strongly blocked IgE ϩ TNP-induced TNF production ( Fig. 1 , b-e), suggesting a role for IKK in IgE-dependent TNF production. These inhibitors by themselves had little effects on MC TNF production ( Fig. 1 , a-e) and did not affect MC viability as tested by trypan blue assay (data not shown). In addition, the dimethyl sulfoxide (diluents for SC-514) had little effects on MC TNF production (Fig. 1d) .
To determine effects of sulindac on TNF mRNA expression, BMMC, with or without sulindac (5 mM, 1 h pretreatment) treatment, were stimulated with TNP-BSA and subjected to real-time RT-PCR analysis for TNF expression. Using values from the untreated, resting MC as a calibrator, TNP-BSA stimulation induced a 43-fold increase of TNF mRNA relative to the untreated MC. Sulindac inhibited TNP-induced TNF mRNA to the level of 6.8-fold, relative to the untreated MC.
To examine if IKK inhibitors affect IgE-dependent MC degranulation, IgE-sensitized mBMMC were pretreated with various concentrations of BMS-345541 (1, 10, or 100 g/ml) or sulindac (1 or 5 mM) for 60 min and stimulated with TNP-BSA (10 ng/ml). Histamine release was determined. We found that BMS-345541 had little effect on MC degranulation, and sulindac, at the concentration of 5 mM, blocked histamine release (data not shown). These results support the concept that MC degranulation and cytokine TNF production are two separate events. Additional studies are needed to define if IKK is involved in IgE-dependent MC degranulation.
Ag ϩ IgE stimulation induces activation of the IKK␣-IB␣-NF-B pathway and IB␣ but not IKB␤ regeneration
To determine if IgE ϩ Ag stimulation induces IKK activation, IgE-sensitized mBMMC were stimulated with TNP-BSA for 40 min, and cytoplasmic proteins were used to examine IKK␣ and IKK␤ phosphorylation and total protein levels. Initially, protein samples in PVDF membranes were blotted with an antibody, which sees phosphorylated forms of IKK␣ and IKK␤ [p-IKK␣ (Ser180)/IKK␤ (Ser181), Cell Signaling Technology]. It is interesting that phosphorylation of IKK␣ but not IKK␤ was detected in cells following TNP-BSA stimulation (Fig. 2a , p-IKK␣/IKK␤ panel). To verify the expression of IKK␣ and IKK␤ expression in MC, the same PVDF membrane was sequentially stripped and blotted using two additional antibodies. One specifically recognizes IKK␣ (Cell Signaling Technology), and the other recognizes IKK␤ with partial reaction with IKK␣, according to the manufacturer (Santa Cruz Biotechnology). MC express IKK␣ ( To determine IgE-dependent activation of the IKK-IB-NF-B pathway, phosphorylation and total protein levels of members of the IKK-IB-NF-B family were determined following IgE ϩ TNP stimulation. Cytoplasmic proteins from BMMC, with or without treatment with TNP-BSA (10 ng/ml), were separated by SDS-PAGE and analyzed with various antibodies in different blots. TNP stimulation induced a significant and rapid (5 min) phosphorylation of IKK␣, which lasted up to 3 h (Fig. 2b, top panel) . It is interesting that no IKK␤ phosphorylation was observed, as this antibody sees p-IKK␣ (Ser180) and p-IKK␤ (Ser181).
IgE ϩ TNP induced rapid (5 min) phosphorylation of IB␣, which maintained over 6 h (Fig. 2b, p-IB␣ panel) . IgE ϩ TNP-induced degradation of constitutive IB␣ can be seen readily after 20 min stimulation, which was followed by a prominent regeneration of IB␣ (Fig. 2b, Total IB␣ panel) . There was a decrease of IB␣ phosphorylation level at 20 min, which is likely a result of the decrease of total IB proteins at this time-point because of the degradation of IB␣ after initial phosphorylation (5 min). It is noticeable that phosphorylation of IB␣ was evident after TNP stimulation for 40 min-6 h (Fig.  2b, p-IB␣ panel) , suggesting that newly generated IB␣ was again phophorylated after TNP stimulation. Total IB␤ protein levels remained constant before or after IgE ϩ TNP stimulation (Fig. 2b, Total IB␤ panel) . An increase of NF-B p65 protein level was observed after IgE ϩ TNP stimulation (Fig. 2b,  NF-B, p65 panel) , suggesting a regeneration of this protein after TNP stimulation.
No effect of histamine on IKK␣ phosphorylation was observed when BMMC were treated with histamine (10 g/ml) for 5 min (data not shown). This excludes the possibility that IgE ϩ TNP-induced IKK␣ phosphorylation is a secondary effect induced by histamine following degranulation.
Sulindac blocked IgE ϩ TNP-induced IKK-IB-NF-B pathway activation and TNF production by mBMMC
Sulindac is a widely used, nonsteroidal, anti-inflammatory agent, which has inhibitory effects for IKK [19, 21] . To determine if sulindac inhibits IgE-dependent TNF production through IKK-related mechanisms, IgE-sensitized BMMC were pretreated with sulindac (5 mM) for 2 h and then were stimulated with TNP-BSA (10 ng/ml) for 5 or 40 min. As shown in phosphorylation at 5 min and 40 min was also inhibited by sulindac treatment (Fig. 3, p-IB␣ panel) . TNP-induced IB␣ degradation at 5 min was blocked by sulindac (Fig. 3, Total  IB␣ panel) . It is noteworthy that at 40 min after TNP stimulation, a decreased level of total IB␣ was observed in sulindac-treated cells (Fig. 3, Total IB␣ panel) . This is likely a result of the combination of a low level of IB␣ degradation and decreased IB␣ regeneration in these cells following sulindac and TNP-BSA cotreatment.
To determine the effect of sulindac on IgE-dependent NF-B activation, IgE-sensitized BMMC were treated with sulindac for 2 h before TNP stimulation. NF-B activation was determined by EMSA. Sulindac treatment inhibited IgE ϩ TNP-induced NF-B activation (Fig. 4a) . To verify the specific binding of NF-B with 32P-labeled NF-B oligonucleotide, nuclear proteins from TNP-activated MC were incubated with anti-p50 or anti-p65 antibodies. The anti-p50 antibody induced a complete shift of the NF-B-binding band. In addition, 100ϫ concentrated, unlabeled NF-B oligonucleotide (cold probe) was used to compete with 32P-labeled NF-B oligonucleotide, and 100ϫ concentrated, unlabeled AP-1 oligonucleotide was used as a nonspecific control probe. The specific inhibition of NF-B binding by the cold NF-B probe but not by the AP-1 probe further supports the specificity of NF-B binding in our EMSA experiments (Fig. 4b) .
To examine the correlations between the effects of sulindac on IgE-dependent NF-B activation and TNF production, cellfree supernatants collected from sulindac-treated cells as described in Figure 4a were used to determine TNF by ELISA. Consistent with the inhibitory effects of sulindac on IKK, IB␣, and NF-B activation, treatment with sulindac completely blocked IgE ϩ TNP-induced cytokine TNF production (Fig. 4c) .
To determine a concentration-dependent effect of sulindac on IgE-dependent MC activation, IgE-sensitized BMMC were pretreated with sulindac at the concentrations of 0.1, 1, and 5 mM for 2 h and stimulated with TNP for 6 h. As shown in Figure 5 , a-c, TNP-induced phosphorylation and synthesis of IKK␣ and IB␣ and activation of NF-B were blocked by sulindac in a concentration-dependent manner.
PDTC blocks FcRI-dependent cytokine production and synthesis of IB and NF-B
In addition to NF-B, several transcription factors such as AP-1 and NF of activated T cells have been implicated in IgE-dependent MC cytokine production [22] . To examine the Fig. 4 . Sulindac inhibits IgE-dependent NF-B activation and TNF production. Anti-TNP, IgE-sensitized BMMC were treated with an IKK inhibitor sulindac (5 mM) for 2 h or sham-treated with medium and then stimulated with TNP-BSA (10 ng/ml) for 5, 20, and 40 min and 1, 3, or 6 h or were unstimulated (NT). (a) Nuclear extracts were isolated and analyzed by EMSA using 32P-labeled NF-B oligonucleotide. (b) To verify the specificity binding of NF-B with oligonucleotide probe, TNP-activated MC nuclear proteins were incubated with anti-p50 or anti-p65 antibodies (Ab). Furthermore, 100ϫ concentrated, unlabeled NF-B oligonucleotide was used to compete with 32P-labeled NF-B oligonucleotide, and 100ϫ concentrated, unlabeled activator protein-1 (AP-1) oligonucleotide was used as a nonspecific control probe. (c) Cell-free supernatants were used to determine TNF levels by ELISA.
importance of the IKK-IB-NF-B pathway in IgE-dependent TNF production, BMMC were pretreated with a NF-B inhibitor PDTC before TNP stimulation. PDTC inhibited IgE ϩ TNP-induced TNF production in a dose-dependent manner (Fig. 6a) , suggesting a role for NF-B in IgE-dependent MC TNF production.
IgE ϩ TNP-induced stimulation also induces resynthesis of IB␣ and an increase of protein levels of IKK␣, as well as several NF-B family members (Fig. 2b) , suggesting a dynamic involvement of the IKK-IB-NF-B pathway in IgE-induced MC activation. To examine a role for NF-B in IgE-induced IKK and IB synthesis, BMMC were treated with PDTC (50, 100, 500 M) for 1 h before TNP-BSA stimulation. PDTC treatment had little effect on IgE ϩ TNP-induced IKK␣ synthesis, even at the high concentration of 500 M (Fig. 6b , Total IKK␣ panel) but strongly inhibited IB␣ regeneration (Fig. 6b , Total IB␣ panel), suggesting that synthesis of IB␣ but not IKK␣ is regulated by NF-B. It is interesting that although total IB␣ levels were low in PDTC-treated cells, the phosphorylation level of this protein remained high in these cells (Fig. 6b, p-IB␣ panel) , a piece of evidence that deserves further study. In addition, IB␤ protein level was not affected by PDTC treatment (Fig. 6b, Total IB␤ panel) . Basal IB␣ levels appear to be unaffected by PDTC treatment (50 M, 4 h; data not shown).
Stimulation with IgE ϩ TNP induces degradation of IB␣ (20 min), which is followed with regeneration of IB␣ (Fig. 2b , Total IB␣ panel). It is interesting that phosphorylation of IB␣ lasts hours, suggesting that newly synthesized IB␣ becomes phosphorylated (Fig. 2b, p-IB␣ panel) . Thus, IgE ϩ TNP-induced MC cytokine production likely involves constitutively expressed and newly synthesized IB␣. To examine if constitutively expressed IB␣ and other NF-B family members are sufficient in mediating IgE ϩ TNP-induced NF-B activation and cytokine production, PDTC was added to BMMC before and after TNP-BSA stimulation. NF-B activation was significantly inhibited when PDTC was added to BMMC before (1 h or 30 min), together with, or after (20 min) TNP-BSA stimulation (Fig. 6, c and d) . When PDTC was added to BMMC 40 min after TNP stimulation, evident NF-B activities were observed (Fig. 6c) . It is interesting that PDTC only partially inhibited IgE ϩ TNP-induced TNF production when it was added after TNP stimulation (Fig. 6d) , suggesting constitutively expressed and newly synthesized IB and NF-B members are involved in IgE-dependent MC cytokine production.
IgE-dependent IKK␣ phosphorylation was inhibited by Ro 31-8220
To examine the potential mechanisms involved in IgE-dependent IKK␣ phosphorylation, BMMC, after IgE sensitization, were treated for 2 h with several protein kinase inhibitors including PP2 (Src family protein tyrosine kinase inhibitor, 10 M), SB 203580 [p38 mitogen-activated protein kinase (MAPK) inhibitor, 10 M], PD 98059 [MAPK and MAPK kinase (MEK) inhibitor, 50 M], wortmannin (PI-3K inhibitor, 100 nM), and Ro 31-8220 (PKC inhibitor, 5 M). It is interesting that Ro 31-8220 but not other kinase inhibitors blocked IgE ϩ TNP-induced IKK␣ and IB␣ phosphorylation (Fig. 7 , p-IKK␣ and p-IB␣ panels), suggesting a role for PKC in IgE-dependent IKK-IB-NF-B activation. 
DISCUSSION
Although FcεRI-induced NF-B activation and IB phosphorylation have been reported [1, 2] , little is known about the mechanisms directly involved in FcεRI-induced IB-NF-B activation in MC. Depending on the nature of specific stimulireceptor involved, a number of signaling molecules (Ͼ12), including IKK [3, 4] , c-Src [5] , pp90rsk [23] , m-calpain [8] , and others, have been shown to interact directly with IB in different cell types. We examined if IKK is required for IgEdependent cytokine production by MC. Five IKK inhibitors were used including 15dPGJ 2 , BMS-345541, and a peptide that inhibits IKK␣ and IKK␤ activities and SC-514 and sulindac, which inhibit IKK␤. All five IKK inhibitors strongly blocked IgE ϩ TNP-induced TNF production by MC. Moreover, activation of MC by IgE ϩ TNP-BSA induced a rapid IKK␣ phosphorylation (5 min), which was accompanied with a rapid IB␣ phosphorylation (5 min) and subsequent IB␣ degradation, a sustained NF-B activation (Ͼ6 h), and production of TNF. These data support a role for IKK in the initiation of an IKK-IB-NF-B cascade following FcεRI-cross-linking in MC. The rapid phosphorylation of IKK and IB suggests that this effect is most likely directly induced by FcεRI cross-linking and excludes the possibility of the secondary effect induced by MC-secreted mediators such as TNF [24] .
It is noteworthy that no IKK␤ phosphorylation was observed in activated BMMC, although in other cell types, IKK␤ is considered mainly responsible for IB phosphorylation [25, 26] , and IKK␣ is required for processing of NF-B2 [27] . However, this cannot exclude a potential role for IKK␤ in IgE-dependent TNF production, as inhibitors that block IKK␤ activity, such as SC-514 [16] or sulindac [19] , inhibited IgE ϩ TNP-induced TNF production. In addition, a recent report showed IKK␤ phosphorylation in a rat MC line, BRL 2H3 cells [28] . Thus, further study is required to determine the specific contribution of IKK␣ versus IKK␤ in IgE-dependent IB-NF-B pathway activation and subsequent TNF production by MC. Considering the significant role of MC in allergy, our finding of IKK in IgE ϩ TNP-induced signaling in MC, together with a recent report of IKK activation in bronchiolar epithelium of allergic airway [29] , suggests that IKK may have an important role in the pathogenesis of allergic diseases.
Our results also showed that FcεRI cross-linking on MC induces a new synthesis of several signaling molecules including IB␣ and NF-B p65. It is interesting that an IgE-induced increase of IB␣ synthesis is accompanied with a sustained IB␣ phosphorylation without evident IB␣ decrease (degradation; from 40 min to 6 h). This may likely be a result of the fact that IgE-induced synthesis of IB␣ exceeds its degradation. To differentiate the role of the constitutively existed IB and the newly synthesized IB in IgE-dependent MC activation, PDTC was used to block NF-B activity, as IB synthesis is NF-B-dependent. PDTC was added at various times before or after TNP stimulation. When BMMC were initially activated by IgE ϩ TNP, which allows the constitutively existed IB␣ phosphorylation and degradation, and then followed by treatment with PDTC to block the new synthesis of IB, IgE ϩ TNP-induced cytokine production was inhibited. These data support a role for the newly synthesized IB␣ and NF-B p65 in IgE-dependent NF-B activation and cytokine production. The prolonged phosphorylation of IKK, sustained IB␣ phosphorylation, and NF-B activation and significant synthesis of IKK and NF-B families suggest that FcεRI aggregation induces a dynamic IKK-IB-NF-B activation cycle that leads to cytokine production.
Regulation of IgE-dependent IKK activation in MC has not been reported previously. In other cell types, IKK is associated with and regulated by several signaling molecules such as c-Src [30] , PKC [31] , protein phosphatase 2A [32] , or steroid receptor coactivator [33] . In MC, we were unable to demonstrate physical association between IKK and PP2A (data not shown), although such association was shown in MT4 cells [32] . In other cells, IKK␣ is preferentially phosphorylated by NF-B-inducing kinase [34] , and IKK␤ was preferentially phosphorylated by MEK kinase 1 [35] . We attempted to examine mechanisms involved in IgE-dependent IKK activation by using several inhibitors including inhibitors for PKC (Ro 31-8220), Src tyrosine kinase (PP2), PI-3K (wortmannin), MAPK p38 (SB 203580), and MEK (PD 98059). It is interesting that only the PKC inhibitor demonstrated an inhibitory effect on IgE ϩ TNP-induced IKK␣ phosphorylation, suggesting that PKC may serve as an up-stream molecule in IgEinduced MC activation. Consistent with this notion, PKC␤ controls NF-B activation in B cells through selective regulation of the IKK␣ [36] .
Based on these findings, we propose a working model for the regulatory role of IKK in IgE-dependent TNF production (Fig.  8) . Ag-induced cross-linking of IgE-FcεRI mediates PKC activation and subsequent IKK activation, leading to IB␣ phosphorylation and degradation. This allows NF-B to translocate into the nucleus and initiates TNF production. Activation of NF-B also induces new synthesis of IB␣ and NF-B p65. As newly synthesized IB␣ is phosphorylated rapidly during Ag stimulation, which is accompanied with prolonged phosphorylation of IKK␣ and sustained NF-B activation, FcεRI aggregation induces a dynamic IKK␣-IB␣-NF-B activation cycle that leads to TNF production. Blockade of IKK␣-IB␣-NF-B pathway activation and subsequent TNF production by IKK inhibitors or by NF-B inhibitor PDTC suggests an essential role of this pathway in IgE-dependent MC TNF production. 
